GLOW Glow Lifetech Corp.

0.0245USD0.0350 CAD · CNQ0.00%Mkt Cap: 4.71M USDP/E: —

Glow Lifetech Corp., an ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products. It engages in the commercialization of plant-based MyCell technology delivery system; water-solubl…

Key Statistics

Company
Market Cap4.71M USD
Enterprise Value3.62M USD
Revenue (TTM)1.61M USD
Gross Profit952.23K USD
Net Income (TTM)-431.91K USD
Revenue/Share0.0091 USD
Last Price0.0245 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA37989H1091
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-22.38
EV/Revenue2.24
P/S2.92
P/B2.19
EPS (TTM)0.00 USD
EPS (Forward)—
52W Range
0.02450% of range0.0454
52W High0.0454 USD
52W Low0.0245 USD
Profitability
Gross Margin66.33%
Oper. Margin-18.31%
EBITDA Margin-10.03%
Profit Margin-30.09%
ROE-22.80%
ROA-15.78%
ROIC-41.06%
ROCE-26.74%
Growth
Revenue Growth19.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.50K USD
CapEx (TTM)72.12K USD
FCF Margin11.79%
FCF Yield4.04%
Net Debt-1.09M USD
Net Debt/EBITDA6.75
Net Debt/FCF-5.74
Balance Sheet
Debt/Equity0.02
Current Ratio2.63
Quick Ratio1.93
Book Value/Sh0.01 USD
Cash/Share0.0056 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.192.44M
Float138.44M
Insiders23.18%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short5.65K
Short (prev mo.)5.02K
Technical
SMA 500.0282 (-13.4%)
SMA 2000.0322 (-24.1%)
Beta0.69
S&P 52W Chg12.00%
Avg Vol (30d)94.93K
Avg Vol (10d)62.12K
Technical Indicators
RSI (14)31.7
MACD-0.0019
MACD Signal-0.0016
MACD Hist.-0.0003
BB Upper0.0301 USD
BB Middle0.0266 USD
BB Lower0.0231 USD
BB Width26.45%
ATR (14)0.0006 USD
Vol Ratio (20d)0.43x

About Glow Lifetech (CNSX: GLOW)

›

Glow Lifetech (CNSX: GLOW) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 0.0350 CAD on 19 November 2026, down 36.4% over 52 weeks. Its 52-week range is 0.0350 CAD to 0.0650 CAD, and it trades at the bottom of that range.

Its market capitalisation is 6.74M CAD.

Glow Lifetech reports return on equity of -22.8%, an operating margin of -18.3% and revenue up 19.9% year over year.

It holds more cash than debt, a net cash position of 1.56M CAD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.